By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Orbus Neich 

25th Floor, Neich Tower

Hong Kong      China
Phone: 852-2802-2288 Fax: 852-2507-3532


Medical Device

Company News
Orbus Neich, Boston Scientific Corporation (BSX) Settle Patent Litigation 9/17/2013 7:52:56 AM
Orbus Neich Says Boston Scientific Corporation (BSX) is Misleading Preliminary Court Injunction 5/14/2013 8:20:29 AM
Orbus Neich's Genous(TM) Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents 12/2/2010 11:28:54 AM
Orbus Neich Issues Statement on Boston Scientific Corporation (BSX)'s Unsuccessful Retaliatory Litigation Efforts in the Netherlands 12/1/2010 7:27:57 AM
Unique Studies with Orbus Neich's Genous(TM) Stent Further Validate Early Endothelial Progenitor Cell Coverage and Reduced Thrombogenicity in Human Circulating Blood Compared to Bare Metal Stents 11/23/2010 10:42:19 AM
Randomized Clinical Trial of Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) in China Completes Patient Enrollment 10/11/2010 10:06:52 AM
Data from Multiple Clinical Trials of Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010 9/27/2010 8:28:11 AM
Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 9/24/2010 8:43:17 AM
Patient Enrollment Completed in First Randomized Clinical Study of Orbus Neich's Combo(TM) Bio-engineered Sirolimus Eluting Stent 9/24/2010 8:36:33 AM
100 Percent Coverage of Struts and Complete Neointimal Coverage of Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) Demonstrated 26 Days Post-Implantation in STEMI Patient 8/23/2010 11:13:23 AM